Arrowhead Research (ARWR) Late Breaker AASLD Status Not Expected Until 10 AM, Says Deutsche Bank

Arrowhead Research (NASDAQ: ARWR) late breaker status is expected at 10 AM, said analyst Alethia Young of Deutsche Bank in research report, noting differences compared to Intercept Pharma (NASDAQ: ICPT).

"While ICPT announced earlier today that they will not be presenting FLINT as a later breaker, we think that the Arrowhead situation is different. Recall, Arrowhead runs and controls their own trial. While it does remain uncertain whether they will be accepted as a late breaker, the ICPT situation is case specific," said Young.

You May Also Be Interested In

• Deutsche Bank Upgrades MSCI Inc. (MSCI) to Buy, 'Compelling entry point for long-term investors'
• Pivotal Research Upgrades Sirius XM Radio (SIRI) to Buy, 'Free Cash Flow Acceleration Story'
• Wolfspeed (WOLF) PT Lowered to $30 at Deutsche Bank